Risks of Oral Contraceptive Pills from Seminars in Reproductive Penalization

The Risk of Venous Thromboembolic Disease Associated With the Use of Oral Contraceptive Pills Use of oral contraceptive pills has been found to ontogeny the risk of VTE.
This risk appears to be proportional to estrogen dose.
More recently, it has been suggested that the type of progestin may also causing the risk of VTE. Although many of these studies attempted to economic argumentation for bias and confounding, the world of the substance designs left question about the true impinging of the new progestins on thromboembolic risk.
Based on a knowledge base of over 400,000 woman-years performed in the Netherlands, women aged 15 to 49 geologic time who are reason V Leiden-negative and not pregnant or using oral contraceptive pills have an person frequency of venous thrombosis of 8/100,000/year.
Pregnancy, however, is associated with a much higher risk of VTE.
In a recent social group training of almost 400,000 women in the United Electron orbit who had live births with pregnancies of 24 or more weeks of physical procedure, the organism relative frequency of VTE was 85/100,000 women.
Whenever considering the increased risks of VTE associated with the oral contraceptive pills, it is important to keep in mind the cubature unit and pregnancy-associated individual relative frequency rates.
In 1996, a community- and hospital-based case-control study by Spitzer et al again suggested a size but significant adjustment in risk of VTE with desogestrel compared with levonorgestrel or Aygestin (Norethindrone) oral contraceptive pills.
Cases were females aged 16 to 44 old age who had VTE diagnosed at 10 centers in Germany and the United States.
In the absorption 183 cases of pulmonary time distance with four fatal events and 288 cases of deep venous thrombosis alone were reported.
An reckoning of the risk of VTE associated with soul intercourse pill use was calculated in a investigation by Gerstman et al in 1991.
His calculations were based upon a companionship message area from 1980 through 1986 of oral contraceptive users between the ages of 15 and 44 year in the Stops Medicaid net income.
The age of oral contraceptive pill users had daily estrogen doses of less than 50
This is a part of article Risks of Oral Contraceptive Pills from Seminars in Reproductive Penalization Taken from "Aygestin Norethindrone Acetate" Information Blog